Element Biosciences Accelerates Rollout of Direct In Sample Sequencing for the AVITI24™ Intelligent Multiomics System to Meet Growing Demand
Element Unveils AVITI24™ Innovation Roadmap Ahead of the Advances in Genome Biology and Technology (AGBT) 2025 Annual Meeting
Element Biosciences Launches Trinity™ – A Revolutionary Targeted Sequencing Innovation to Streamline Genomic Research
Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth
Element Biosciences Fortifies its Executive Team with Experts in Artificial Intelligence and Product Development